This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Xolair
  • /
  • Omalizumab as Monotherapy and as Adjunct Therapy t...
Clinical trial

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants (OUtMATCH)

Read time: 2 mins
Last updated:7th Apr 2021
Status: Recruiting
Identifier: NCT03881696
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest